Oakland, CA, United States of America

Walter H Moos

This inventor holds 40 USPTO granted patents and 1 EPO patent, primarily in Mitochondrial Function. Top assignees: Warner-Lambert Company, Chiron Corporation, Migenix, Inc.. Active years: 1985-2006.


% Patents Active = 85.0


Average Co-Inventor Count = 3.6

ph-index = 13

Forward Citations = 646(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (1985 - 1992)
  • Emeryville, CA (US) (1994 - 1996)
  • Oakland, CA (US) (1994 - 2006)

Company Filing History:


Years Active: 1985-2006

Loading Chart...
Loading Chart...
Areas of Expertise:
Adenine Nucleotide Translocator
Mitochondria
Cholinergic Agents
Oligomers
Opiate Receptor Ligands
Oxime Compounds
Cognitive Decline
Polycyclic Amine Derivatives
Muscarinic Agents
Depression Treatment
Cellular Responses
Mitochondria Associated Diseases
40 patents (USPTO):Explore Patents

Title: The Innovative Journey of Walter H Moos

Introduction: Walter H Moos is a renowned inventor based in Oakland, California, known for his groundbreaking contributions to various fields through his inventive spirit and dedication to innovation.

Latest Patents: Walter H Moos holds several patents in diverse areas, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning several decades, Walter H Moos has established himself as a prolific inventor with a keen eye for identifying gaps in the market and developing novel technologies to address them.

Collaborations: Throughout his career, Walter H Moos has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Walter H Moos continues to inspire the next generation of inventors with his innovative mindset and passion for creating solutions that have a lasting impact on society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…